Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2023-07-17 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房2023年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the company's 2023 second extraordinary general meeting of shareholders. It includes details about the meeting date, location, attendance, voting results, and legal witness statements. There is no financial data or report content, only the voting results and procedural compliance information. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting outcomes, not a full report or presentation.
2023-07-17 Chinese
湖南启元律师事务所关于益丰大药房连锁股份有限公司2023年第二次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and validity of the procedures, attendance, and voting results of the company's 2023 second extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document is not a report of financial results, audit, or management discussion, but a legal opinion on the shareholders' meeting process and outcomes. It is not an announcement of voting results per se, but a legal opinion letter related to the meeting. Given the nature of the document as a legal opinion on a shareholders' meeting, it fits best under Regulatory Filings (RNS), which covers miscellaneous filings that do not fit other categories, including legal opinions and compliance documents. The document length is 3150 characters, which is relatively short and consistent with a legal opinion letter rather than a full report. Therefore, the classification is Regulatory Filings (RNS).
2023-07-17 Chinese
内部审计制度
Governance Information Classification · 95% confidence The document is titled '内部审计制度' which translates to 'Internal Audit System' or 'Internal Audit Policy'. It details the internal audit responsibilities, principles, procedures, reporting, evaluation, and archiving within the company. It is a comprehensive internal governance document about the company's internal audit function and its operational framework. It does not contain financial statements, audit opinions on financials, or external audit results. It is not an audit report (AR) in the sense of an external or regulatory audit report, nor is it an annual or interim financial report. It is also not a regulatory filing or announcement but a governance-related internal policy document. Therefore, the best fitting category is Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices, including internal audit policies.
2023-07-14 Chinese
子公司管理制度
Governance Information Classification · 95% confidence The document is titled '子公司管理制度' which translates to 'Subsidiary Management System' and contains detailed internal governance, management, financial, operational, and reporting policies for subsidiaries of the company. It references company law, stock exchange listing rules, and company articles of association. The content is a comprehensive internal policy document outlining governance structures, personnel management, financial controls, investment decision-making, information disclosure, internal audit supervision, and performance evaluation related to subsidiaries. There is no indication that this is an annual report, audit report, earnings release, or any other financial report. It is not a regulatory filing or announcement but a governance and management system document. Therefore, the most appropriate classification is Governance Information (CGR). The document length (5708 characters) supports it being a substantive policy document rather than a brief announcement.
2023-07-14 Chinese
内幕信息知情人登记、报备和保密制度
Governance Information Classification · 95% confidence The document is a detailed internal policy and procedural document regarding insider information management, registration, confidentiality, and compliance within the company. It references relevant laws and regulatory bodies such as the China Securities Regulatory Commission and Shanghai Stock Exchange. The content focuses on the company's internal governance and compliance framework for handling insider information, including responsibilities of the board, management, and other personnel. It does not contain financial statements, earnings data, or investor presentation material. It is not an announcement or a report of financial results or corporate actions but rather a governance and compliance document outlining internal rules and procedures. Therefore, the document best fits the category of Governance Information (CGR).
2023-07-14 Chinese
关于回复上海证券交易所《关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券的审核中心意见落实函》的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the receipt of a regulatory review letter from the Shanghai Stock Exchange about the company's application to issue convertible bonds to unspecified investors. It discusses the review process, submission of related documents, and the need for further approvals before implementation. The document is short (789 characters) and serves as a regulatory update on the financing activity rather than a detailed financial report or the actual issuance of bonds. It does not contain financial statements or detailed financial data but rather informs about the ongoing capital raising process and regulatory compliance. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2023-07-14 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.